We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SLDB market cap is 178.2M. The company's latest EPS is USD -2.4031 and P/E is -1.86.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.84M | -23.11M | -22.64M | -26.86M | -27.79M |
| Net Income | -24.63M | -20.98M | -20.34M | -24.3M | -25.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 13.62M | 8.09M | 0 |
| Operating Income | -119.32M | -88.41M | -72.25M | -106.45M | -104.25M |
| Net Income | -117.22M | -88.29M | -72.19M | -85.98M | -96.02M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 204.72M | 184.73M | 164.94M | 248.69M | 230.98M |
| Total Liabilities | 40.99M | 40.37M | 38.46M | 37.97M | 37.74M |
| Total Equity | 163.73M | 144.36M | 126.48M | 210.72M | 193.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 103.47M | 171.17M | 232.38M | 260.25M | 164.94M |
| Total Liabilities | 23.42M | 39.08M | 24.17M | 48.59M | 38.46M |
| Total Equity | 80.05M | 132.09M | 208.21M | 211.67M | 126.48M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -55.46M | -73.36M | -94.18M | -25.19M | -46.66M |
| Investing | -10.97M | -35.61M | 9.69M | -38.49M | -43.67M |
| Financing | 2.62M | 2.62M | 3.12M | 107.24M | 112.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -92.71M | -56.6M | -77.76M | -97.98M | -94.18M |
| Investing | 24.52M | 6.6M | -91.09M | 59.16M | 9.69M |
| Financing | 57.88M | 128.7M | 134.99M | 74.83M | 3.12M |
| Market Cap | 178.2M |
| Price to Earnings Ratio | -1.86 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.41 |
| Price to Book Ratio | 1.41 |
| Dividend Yield | - |
| Shares Outstanding | 39.95M |
| Average Volume (1 week) | 321.08k |
| Average Volume (1 Month) | 295.74k |
| 52 Week Change | -14.07% |
| 52 Week High | 15.05 |
| 52 Week Low | 4.36 |
| Spread (Intraday) | 3.56 (65.93%) |
| Company Name | Solid Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.solidbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
